|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Partial vesting on 13 August 2024 of Conditional Share awards
granted on 13 August 2021 under the Smith & Nephew Global Share
Plan 2020, and subsequent sale of shares to cover tax
liability
|
Date of Transaction
|
2024 - 08 - 13
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Craig Gaffin (President Orthopaedics)
|
PDMR
|
11.403054
|
595 (of which 146 were sold and 449 were retained.)
|
N/A Single Transaction
|
Alison Parkes (Chief Compliance Officer)
|
PDMR
|
11.403054
|
1,218 (of which 447 were sold and 771 were retained.)
|
N/A Single Transaction
|
Reason for the notification
|
|
Initial notification /Amendment
|
Initial notification
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|
Name
|
Smith & Nephew plc
|
LEI
|
213800ZTMDN8S67S1H61
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
|
Description
of the financial instrument, type of instrument
|
Smith
& Nephew plc ordinary shares of USD 0.20 each
|
Identification code
|
ISIN: GB0009223206
|
Nature of the transaction
|
Partial vesting on 11 August 2023 of Conditional Share awards
granted on 11 August 2024 under the Smith & Nephew Global Share
Plan 2020, and subsequent sale of shares to cover tax
liability
|
Date of Transaction
|
2024 - 08 - 13
|
Place of Transaction
|
London Stock Exchange (XLON)
|
Name
(Position)
|
Status
|
Price (£)
|
Volume
|
Aggregated information
|
Rohit Kashyap
(President, Advanced Wound Management and Global Commercial
Operations)
|
PDMR
|
11.403054
|
23,201 (of which 5,670 were sold and 17,531 were
retained.)
|
N/A Single Transaction
|
|
|
|
|
|
Smith & Nephew plc
|
|
|
(Registrant)
|
|
|
|
|
|
|
Date:
August 14, 2024
|
By:
|
/s/
Helen Barraclough
|
|
|
Helen
Barraclough
|
|
|
Company
Secretary
|